Literature DB >> 10069533

Ischemia induces metallothionein III expression in neurons of rat brain.

S Yanagitani1, H Miyazaki, Y Nakahashi, K Kuno, Y Ueno, M Matsushita, Y Naitoh, S Taketani, K Inoue.   

Abstract

Metallothionein III (MT-III) is a brain-specific member of the metallothionein family and binds zinc in vivo. In order to confirm the precise localization of MT-III in normal rat brain and the change of MT-III expression after transient whole brain ischemia, we raised a high affinity phagemid-antibody specific for rat MT-III. Immunohistochemical analysis revealed that MT-III in normal brain is localized abundantly in neuronal cell bodies in CA1-3 regions of hippocampus, dentate gyrus, cerebral cortex, olfactory bulb and Purkinje cells in cerebellum. This expression pattern of MT-III was similar to that of MT-III mRNA observed by in situ hybridization studies. ELISA and Northern blot analysis revealed that MT-III protein as well as mRNA levels were up-regulated in cerebrum soon after ischemic stress. Immunohistochemical analysis also demonstrated intense staining in neurons in injured brain after ischemia, which distributed in the same regions as in normal brain. These results suggest that MT-III plays an important role in protecting neurons from ischemic insult by reducing neurotoxic zinc levels and inhibits uncontrolled growth of neurites after ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069533     DOI: 10.1016/s0024-3205(98)00612-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  The role of zinc in cerebral ischemia.

Authors:  Sherri L Galasso; Richard H Dyck
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

2.  Novel Defense by Metallothionein Induction Against Cognitive Decline: From Amyloid β1-42-Induced Excess Zn2+ to Functional Zn2+ Deficiency.

Authors:  Atsushi Takeda; Haruna Tamano; Wakana Hashimoto; Shuhei Kobuchi; Hiroki Suzuki; Taku Murakami; Munekazu Tempaku; Yuta Koike; Paul A Adlard; Ashley I Bush
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

3.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

4.  Metal binding and interdomain thermodynamics of mammalian metallothionein-3: enthalpically favoured Cu+ supplants entropically favoured Zn2+ to form Cu4 + clusters under physiological conditions.

Authors:  Matthew R Mehlenbacher; Rahma Elsiesy; Rabina Lakha; Rhiza Lyne E Villones; Marina Orman; Christina L Vizcarra; Gabriele Meloni; Dean E Wilcox; Rachel N Austin
Journal:  Chem Sci       Date:  2022-04-04       Impact factor: 9.969

Review 5.  Extracellular Zn2+-Dependent Amyloid-β1-42 Neurotoxicity in Alzheimer's Disease Pathogenesis.

Authors:  Yuichi Sato; Mako Takiguchi; Haruna Tamano; Atsushi Takeda
Journal:  Biol Trace Elem Res       Date:  2020-04-13       Impact factor: 3.738

6.  Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage.

Authors:  Grant C O'Connell; Megan L Alder; Christine G Smothers; Julia H C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-06       Impact factor: 11.205

7.  Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.

Authors:  Ryan P Lange; Allen Everett; Pratima Dulloor; Frederick K Korley; Chetan Bettegowda; Cherie Blair; Stuart A Grossman; Matthias Holdhoff
Journal:  Cancer Invest       Date:  2014-07-14       Impact factor: 2.176

8.  Metallothionein-II inhibits lipid peroxidation and improves functional recovery after transient brain ischemia and reperfusion in rats.

Authors:  Araceli Diaz-Ruiz; Patricia Vacio-Adame; Antonio Monroy-Noyola; Marisela Méndez-Armenta; Alma Ortiz-Plata; Sergio Montes; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-02-25       Impact factor: 6.543

Review 9.  Metallothionein in Brain Disorders.

Authors:  Daniel Juárez-Rebollar; Camilo Rios; Concepción Nava-Ruíz; Marisela Méndez-Armenta
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.